颅内生殖细胞瘤的实践模式与生存结局:美国国家癌症数据库分析
研究基于美国国家癌症数据库(NCDB)2004—2014年445例颅内生殖细胞瘤患者,比较单纯放疗(RT)与化疗后放疗(C+RT)的实践模式及生存。成人65.7%接受RT、34.3%接受C+RT,儿童31.8%接受RT、68.2%接受C+RT;C+RT组放疗剂量更低(p<0.001)。全队列5年与10年总生存分别为92.6%和87.9%,两种治疗方式生存无差异。
要点
- 成人以单纯放疗为主(65.7%),儿童以化疗后放疗为主(68.2%)。
- 化疗后放疗组较单纯放疗组放疗剂量更低(p<0.001)。
- 全队列5年与10年总生存分别为92.6%和87.9%。
核心结论
- 颅内生殖细胞瘤治疗中化疗后放疗使用增加且伴随放疗剂量降低,NCDB队列中单纯放疗与化疗后放疗的生存无差异。
研究设计与样本
- 回顾性分析美国国家癌症数据库(NCDB)脑肿瘤登记处2004—2014年445例颅内生殖细胞瘤患者,排除远处转移、未接受治疗或仅手术/化疗者,以>21岁定义成人,按单纯放疗(RT)与化疗后放疗(C+RT)分层。
主要发现
- 成人中65.7%接受RT、34.3%接受C+RT,儿童中31.8%接受RT、68.2%接受C+RT。
- C+RT组放疗剂量低于RT组(p<0.001)。
- 全队列5年与10年总生存分别为92.6%和87.9%。
- 单因素分析显示较年轻年龄、私人保险、C+RT治疗及儿童患者与更好OS相关,多因素分析仅年龄和保险类型保持显著。
- 儿童患者5年OS为RT组92.6% vs C+RT组97.2%(p=0.307),成人患者为RT组83.4% vs C+RT组95.4%(p=0.122)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The goal of the study is to examine the practice pattern and survival outcome of adult and pediatric patients with intracranial germinoma. Patients from the National Cancer Database (NCDB) brain tumor registry between the years 2004-2014 with intracranial germinoma were extracted for analysis. Patients who had distant metastasis, received no treatments, or only surgery/chemotherapy alone were excluded. An age cutoff of > 21 years old was used to define the pediatric population. Patients were stratified by the treatments radiation therapy alone (RT) and chemotherapy followed by radiation therapy (C + RT). 445 patients with intracranial germinoma meeting our inclusion criteria were identified. Of the adult patients, 65.7% received RT and 34.3% received C + RT, compared to the pediatric patients, where 31.8% received RT and 68.2% received C + RT. Those patients who received C + RT had a lower radiation dose compared to the RT group (p < 0.001). The 5 and 10 year overall survival (OS) for the entire cohort was 92.6 and 87.9%, respectively. Univariate analysis demonstrated improved OS with younger age, private insurance, C + RT treatment, and pediatric patients. Only age and insurance type remained significant on multivariate analysis. The 5 year OS was 92.6% (RT) versus 97.2% (C + RT) (p = 0.307) and 83.4% (RT) versus 95.4% (C + RT) (p = 0.122) in the pediatric and adult patients, respectively. There is a higher use of C + RT with an accompanied reduction in RT dose in the treatment of intracranial germinoma. There is no difference in survival between the treatment approaches of RT or C + RT in the NCDB patient cohort.
引用
- Wang WG, Ye H, Chinnaiyan P, et al. Practice patterns and survival outcomes of intracranial germinoma: an analysis of the National Cancer Database. J Neurooncol. 2017. PMID: 29177595. doi:10.1007/s11060-017-2696-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。